Clinical reference Biomarker Directory
Back to directory

Anti-double stranded DNA antibodies

Established

Anti-dsDNA is a specific lupus marker often tracking disease activity, especially renal involvement.

Also known as Anti-dsDNA native DNA antibody
In plain language

This antibody attacks the body's own DNA and is a strong clue for lupus, especially kidney involvement. Its reliability depends partly on which lab test platform was used, since not all commercial tests meet the same accuracy standard.

Biomarker & context

Anti-double stranded DNA (anti-dsDNA) antibodies target native DNA and are one of the most specific serologic markers for systemic lupus erythematosus (SLE), often correlating with disease activity, particularly lupus nephritis.

What it indicates

High-titer anti-dsDNA supports an SLE diagnosis and often rises during disease flares, especially kidney involvement; it is one of two SLE-specific antibodies (with anti-Sm) weighted in current classification criteria.

Diagnosis & clinical testing

Measured via immunoassay; the 2019 EULAR/ACR criteria specifically require the assay used to have ≥90% specificity against a relevant disease control group — not all commercial platforms meet this bar, affecting result reliability depending on which assay was used.

Guiding treatment

Rising anti-dsDNA titers, especially alongside falling complement levels, can prompt closer monitoring for lupus nephritis flare and may influence timing of treatment escalation.

Clinical significance

Reliability depends on assay specificity; used both diagnostically and to monitor lupus nephritis flares.

References
  1. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology.